(Q38956252)

7 September 2017

title

WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo (English)

1 reference

7 September 2017

11

Martin Bornhäuser

1 reference

7 September 2017

13

Lorenz C Hofbauer

1 reference

7 September 2017

12

Martina Rauner

1 reference

7 September 2017

3

Tilman D Rachner

1 reference

7 September 2017

Stefanie Thiele

1

1 reference

7 September 2017

Andy Göbel

2

1 reference

7 September 2017

Susanne Fuessel

4

1 reference

7 September 2017

Michael Froehner

5

1 reference

7 September 2017

Michael H Muders

6

1 reference

7 September 2017

Gustavo B Baretton

7

1 reference

7 September 2017

Ricardo Bernhardt

8

1 reference

7 September 2017

Franz Jakob

9

1 reference

7 September 2017

Claus C Glüer

10

1 reference

7 September 2017

publication date

1 March 2015

1 reference

Journal of Bone and Mineral Research

7 September 2017

published in

1 reference

7 September 2017

volume

30

1 reference

7 September 2017

issue

3

1 reference

7 September 2017

page(s)

471-480

1 reference

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

7 September 2017

cites work

1 reference

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients

21 January 2018

1 reference

Prostate cancer bone metastases promote both osteolytic and osteoblastic activity

21 January 2018

1 reference

Bone-targeting agents in prostate cancer

21 January 2018

1 reference

Multiple functions of the noncanonical Wnt pathway.

21 January 2018

1 reference

Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways

21 January 2018

1 reference

The Wnt pathway: emerging anticancer strategies.

21 January 2018

1 reference

Role of Wnts in prostate cancer bone metastases

21 January 2018

1 reference

Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation

21 January 2018

1 reference

Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics

21 January 2018

1 reference

When prostate cancer meets bone: control by wnts

21 January 2018

1 reference

Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis

21 January 2018

1 reference

Low expression of Wnt-5a gene is associated with high-risk neuroblastoma

21 January 2018

1 reference

Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation

21 January 2018

1 reference

WNT5A expression increases during melanoma progression and correlates with outcome

21 January 2018

1 reference

The role of Wnt5a in prostate gland development

21 January 2018

1 reference

Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase

21 January 2018

1 reference

Elevated level of Wnt5a protein in localized prostate cancer tissue is associated with better outcome

21 January 2018

1 reference

Emphasizing the role of Wnt5a protein expression to predict favorable outcome after radical prostatectomy in patients with low-grade prostate cancer

21 January 2018

1 reference

Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.

21 January 2018

1 reference

WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.

21 January 2018

1 reference

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

NIH Image to ImageJ: 25 years of image analysis

21 January 2018

1 reference

Guidelines for assessment of bone microstructure in rodents using micro-computed tomography

21 January 2018

1 reference

Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma

21 January 2018

1 reference

The opposing roles of Wnt-5a in cancer

21 January 2018

1 reference

Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition

21 January 2018

1 reference

WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer

21 January 2018

1 reference

Wnt5a enhances the response of CML cells to Imatinib Mesylate through JNK activation and γ-catenin inhibition

21 January 2018

1 reference

Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice

21 January 2018

1 reference

Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.

21 January 2018

1 reference

Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.2362

1 reference

7 September 2017

1 reference